Actions

Emerging strategies and options: Difference between revisions

From MalariaETC

No edit summary
No edit summary
Line 4: Line 4:
<span style="font-size:90%">[[MalariaETC Index|1. Main Malaria Index]]''</span></br>
<span style="font-size:90%">[[MalariaETC Index|1. Main Malaria Index]]''</span></br>
<span style="font-size:90%">[[Rapid diagnostic tests (RDTs)|2. RDT main page]]''</span></br>
<span style="font-size:90%">[[Rapid diagnostic tests (RDTs)|2. RDT main page]]''</span></br>
<span style="font-size:90%">[[Rapid diagnostic tests (RDTs)|3. RDT main page]]''</span></br>
<span style="font-size:90%">[[RDT_test:_formats_of_tests|3. RDT Test Design]]''</span></br>
<span style="font-size:90%">Current page: '''Emerging Strategies for RDT Design'''</span>
<span style="font-size:90%">Current page: '''Emerging Strategies for RDT Design'''</span>
----
----

Revision as of 09:52, 29 September 2024


Navigation
1. Main Malaria Index
2. RDT main page
3. RDT Test Design
Current page: Emerging Strategies for RDT Design


EXTRA
Emerging Strategies for RDT design


Multiplexed detection strategies may be used in some circumstances to optimase performance for local need:

(a) Where both P.falciparum and P.vivax are highly prevalent, then tests with specificity for each species may prove valuable - P.falciparum (HRP2) and P.vivax (Pv-pLDH) may be combined with or without a pen-specific antibody. This can offer some advantages in detecting dual infection by the two species.

(b) Where HRP2 deletion are frequent, they may cause a high risk for test failure, tests multiplexed to select for Pf-pLDH and HRP2 may improve detection in these circumstances.